Mabion S.A. (MAB) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.308x

Based on the latest financial reports, Mabion S.A. (MAB) has a cash flow conversion efficiency ratio of -0.308x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-12.06 Million ≈ $-3.32 Million USD) by net assets (zł39.09 Million ≈ $10.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Mabion S.A. balance sheet quality to measure how much of total assets are equity-financed.

Mabion S.A. - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how Mabion S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Mabion S.A. (MAB) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Mabion S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mabion S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Orbit Garant Drilling Inc.
TO:OGD
-0.033x
Kuk Dong
KO:005320
-0.103x
AfroCentric Investment Corp
JSE:ACT
0.106x
Kartal Yenilenebilir Enerji Uretim AS
IS:KARYE
-0.059x
NDFOS Co. Ltd
KQ:238090
-0.005x
Australian Mines Ltd
AU:AUZ
-0.017x
4Mass SA
WAR:4MS
0.110x
Compal Broadband Networks Inc
TW:6674
-0.089x

Annual Cash Flow Conversion Efficiency for Mabion S.A. (2009–2025)

The table below shows the annual cash flow conversion efficiency of Mabion S.A. from 2009 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Mabion S.A..

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 zł48.83 Million
≈ $13.44 Million
zł-41.59 Million
≈ $-11.45 Million
-0.852x -338.12%
2024-12-31 zł111.44 Million
≈ $30.67 Million
zł39.86 Million
≈ $10.97 Million
0.358x +1905.77%
2023-12-31 zł117.78 Million
≈ $32.41 Million
zł-2.33 Million
≈ $-642.08K
-0.020x -103.90%
2022-12-31 zł76.51 Million
≈ $21.06 Million
zł38.84 Million
≈ $10.69 Million
0.508x +182.24%
2021-12-31 zł53.31 Million
≈ $14.67 Million
zł-32.91 Million
≈ $-9.06 Million
-0.617x -235.56%
2020-12-31 zł-77.39 Million
≈ $-21.30 Million
zł-35.24 Million
≈ $-9.70 Million
0.455x -70.89%
2019-12-31 zł-21.58 Million
≈ $-5.94 Million
zł-33.76 Million
≈ $-9.29 Million
1.564x +269.28%
2018-12-31 zł42.14 Million
≈ $11.60 Million
zł-38.94 Million
≈ $-10.72 Million
-0.924x -192.46%
2017-12-31 zł-54.16 Million
≈ $-14.91 Million
zł-54.13 Million
≈ $-14.90 Million
0.999x +124.49%
2016-12-31 zł3.73 Million
≈ $1.03 Million
zł-15.22 Million
≈ $-4.19 Million
-4.082x -1433.70%
2015-12-31 zł127.64 Million
≈ $35.13 Million
zł-33.97 Million
≈ $-9.35 Million
-0.266x -988.98%
2014-12-31 zł997.84 Million
≈ $274.62 Million
zł-24.39 Million
≈ $-6.71 Million
-0.024x +53.89%
2013-12-31 zł520.55 Million
≈ $143.26 Million
zł-27.59 Million
≈ $-7.59 Million
-0.053x -615.46%
2012-12-31 zł1.82 Billion
≈ $502.09 Million
zł-13.51 Million
≈ $-3.72 Million
-0.007x +98.71%
2011-12-31 zł20.37 Million
≈ $5.60 Million
zł-11.74 Million
≈ $-3.23 Million
-0.576x -794.40%
2010-12-31 zł21.72 Million
≈ $5.98 Million
zł-1.40 Million
≈ $-385.19K
-0.064x -101.62%
2009-12-31 zł-74.80K
≈ $-20.59K
zł-298.41K
≈ $-82.13K
3.990x --

About Mabion S.A.

WAR:MAB Poland Biotechnology
Market Cap
$33.41 Million
zł121.38 Million PLN
Market Cap Rank
#23381 Global
#225 in Poland
Share Price
zł7.51
Change (1 day)
+1.76%
52-Week Range
zł6.82 - zł9.65
All Time High
zł134.60
About

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland. It offers drug substance manufacturing, fill and finish, gene to vial end-to-end development, process development, analytics, and banking services. In addition, it offers cell line development… Read more